SnusNicotinePouches

Nicotine pouch laboratory results: interpreting not detected and below quantification

Not detected is a laboratory statement tied to a method and reporting limit. It is not proof that a substance is absent. When comparing nicotine pouch reports, confirm the analyte, sample basis and detection capability before using a result in a purchasing or safety decision.

Editorial scope: technical development and supplier review. Published 16 November 2026. The study and control suggestions below are not reported results from this supplier.

Decision sequence: Nicotine pouch laboratory results: interpreting not detected and below quantification
Decision map for Nicotine pouch laboratory results: interpreting not detected and below quantification. No experimental measurements are shown.

Distinguish detection from quantification

The detection limit and quantification limit have different purposes. A signal may be distinguishable from background without being reliably quantified at the required performance. Ask how the laboratory reports those cases. A result written only as pass, ND or less than a number leaves important information missing unless its units and method basis are clear.

Compare the same quantity and sample

Check whether results are per gram, per pouch or per extract volume. Record unit mass, dilution and whether the sample was an individual pouch or a composite. For contaminants, the analyte identity and a suitable reporting limit must match the question. A broad screening method may not support a specific low-level claim.

Use limits suited to the decision

Select appropriate methods and criteria with qualified technical and regulatory input for the exact product and market. A reporting limit above a required threshold cannot establish compliance with that threshold. Chemical purity, a low contaminant result and market authorization remain separate issues. Preserve unknowns instead of converting them into zero in a spreadsheet.

Development review checklist

Buyer questions

Does ND mean none is present?

No. It means the method did not report detection under its stated conditions and limit.

Can below LOQ be treated as a measured zero?

No. Retain the laboratory's qualifier and reporting limit.

Why do laboratories report different limits?

Method, detector, preparation and matrix performance differ.

Can a composite sample establish every unit meets a limit?

Not by itself. The sampling plan and variability need consideration.

Is a lower reporting limit always enough to judge a product safe?

No. Appropriate analytes, reliable methods, exposure assessment and other product requirements still matter.

References and scope

  1. FDA: ICH Q2(R2), Validation of Analytical Procedures

    Fit-for-purpose analytical validation framework; pharmaceutical guidance used as technical background, not a certification for these products.

  2. ICH Q2(R2), final guideline (2023)

    Specificity, recovery, precision and reportable range; product-specific methods require their own validation.

  3. FDA: Marketing authorization for 20 ZYN products, January 16, 2025

    Historical product-specific authorization, not a current count of all authorized products and not FDA approval or permission for other SKUs.

Discuss the specification and evidence needed for your project. Send the intended use, destination market and the attribute you need to verify. Commercial capability and acceptance criteria require a project-specific agreement.